Karas Eric bought SPRY
June 12, 2026 · Form 4 insider transaction
Karas Eric bought 25,000 shares of ARS Pharmaceuticals, Inc. at $1.50 per share, a transaction worth $37.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$1.50
Total value
$37.5K
InsiderKaras Eric
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 12, 2026
Filing dateJune 12, 2026
Shares owned after37,176
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 1,861 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on December 31, 2025.